Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.
Department of Pharmacology and Physiology, University of Rochester, New York, USA.
Sci Rep. 2017 Aug 15;7(1):8296. doi: 10.1038/s41598-017-08373-4.
The intracellular scaffold KRIT1/CCM1 is an established regulator of vascular barrier function. Loss of KRIT1 leads to decreased microvessel barrier function and to the development of the vascular disorder Cerebral Cavernous Malformation (CCM). However, how loss of KRIT1 causes the subsequent deficit in barrier function remains undefined. Previous studies have shown that loss of KRIT1 increases the production of reactive oxygen species (ROS) and exacerbates vascular permeability triggered by several inflammatory stimuli, but not TNF-α. We now show that endothelial ROS production directly contributes to the loss of barrier function in KRIT1 deficient animals and cells, as targeted antioxidant enzymes reversed the increase in permeability in KRIT1 heterozygous mice as shown by intravital microscopy. Rescue of the redox state restored responsiveness to TNF-α in KRIT1 deficient arterioles, but not venules. In vitro, KRIT1 depletion increased endothelial ROS production via NADPH oxidase signaling, up-regulated Nox4 expression, and promoted NF-κB dependent promoter activity. Recombinant yeast avenanthramide I, an antioxidant and inhibitor of NF-κB signaling, rescued barrier function in KRIT1 deficient cells. However, KRIT1 depletion blunted ROS production in response to TNF-α. Together, our data indicate that ROS signaling is critical for the loss of barrier function following genetic deletion of KRIT1.
细胞内支架 KRIT1/CCM1 是血管屏障功能的既定调节因子。KRIT1 的缺失会导致微血管屏障功能下降,并导致血管疾病脑动静脉畸形(CCM)的发生。然而,KRIT1 的缺失如何导致随后的屏障功能缺陷仍未得到明确。先前的研究表明,KRIT1 的缺失会增加活性氧物种(ROS)的产生,并加剧几种炎症刺激引发的血管通透性增加,但不会引起 TNF-α 的增加。我们现在表明,内皮细胞 ROS 的产生直接导致 KRIT1 缺陷动物和细胞中屏障功能的丧失,因为靶向抗氧化酶可逆转血管通透性在 KRIT1 杂合子小鼠中的增加,如活体显微镜所示。氧化还原状态的恢复挽救了 KRIT1 缺陷的小动脉对 TNF-α的反应性,但对小静脉没有作用。在体外,KRIT1 的耗竭通过 NADPH 氧化酶信号增加内皮细胞 ROS 的产生,上调 Nox4 表达,并促进 NF-κB 依赖性启动子活性。重组酵母燕麦蒽酰胺 I 是一种抗氧化剂和 NF-κB 信号抑制剂,可挽救 KRIT1 缺陷细胞的屏障功能。然而,KRIT1 的耗竭会抑制 TNF-α 引起的 ROS 产生。总之,我们的数据表明,ROS 信号对于 KRIT1 基因缺失后屏障功能的丧失至关重要。